ticker,nameOfIssuer,cusip,value,shares,allocation_percent,filingDate,reportDate,accessionNumber
INCY,Incyte Corp.,45337C102,466485000.0,3489822,15.259218794466598,2017-05-10,2017-03-31,0000950123-17-004280
CELG,Celgene Corp,151020104,415509000.0,3339298,13.591739803144842,2017-05-10,2017-03-31,0000950123-17-004280
IONS,Ionis Pharmaceuticals Inc.,462222100,299944000.0,7461295,9.811486161586094,2017-05-10,2017-03-31,0000950123-17-004280
GILD,Gilead Sciences Inc.,375558103,188451000.0,2774596,6.164431956088673,2017-05-10,2017-03-31,0000950123-17-004280
RDUSEUR,Radius Health Inc.,750469207,175486000.0,4540399,5.740333064012273,2017-05-10,2017-03-31,0000950123-17-004280
AGIO,Agios Pharmaceuticals Inc.,00847X104,165828000.0,2839528,5.424409647145796,2017-05-10,2017-03-31,0000950123-17-004280
VRTX,Vertex Pharmaceuticals Inc.,92532F100,159153000.0,1455445,5.206063322069825,2017-05-10,2017-03-31,0000950123-17-004280
ALXN,Alexion Pharmaceuticals Inc.,015351109,149056000.0,1229428,4.875779749891236,2017-05-10,2017-03-31,0000950123-17-004280
NBIX,Neurocrine Biosciences Inc.,64125C109,138627000.0,3201552,4.534636105813736,2017-05-10,2017-03-31,0000950123-17-004280
T8S,Tesaro Inc.,881569107,126878000.0,824582,4.150313862620091,2017-05-10,2017-03-31,0000950123-17-004280
HALO,Halozyme Therapeutics Inc.,40637H109,100438000.0,7749832,3.2854334378996883,2017-05-10,2017-03-31,0000950123-17-004280
REGN,Regeneron Pharmaceuticals Inc.,75886F107,94940000.0,245000,3.1055880303689483,2017-05-10,2017-03-31,0000950123-17-004280
SAGE,Sage Therapeutics Inc.,78667J108,69111000.0,972439,2.260694063269732,2017-05-10,2017-03-31,0000950123-17-004280
ALNY,Alnylam Pharmaceuticals Inc.,02043Q107,63619000.0,1241338,2.0810449220986107,2017-05-10,2017-03-31,0000950123-17-004280
N/A,Kite Pharma Inc.,49803L109,58083000.0,740000,1.8999564942902847,2017-05-10,2017-03-31,0000950123-17-004280
ESPR,Esperion Therapeutics Inc.,29664W105,49736000.0,1408542,1.6269172770005267,2017-05-10,2017-03-31,0000950123-17-004280
N/A,Juno Therapeutics Inc.,48205A109,48485000.0,2185000,1.585995741019996,2017-05-10,2017-03-31,0000950123-17-004280
MGNX,MacroGenics Inc.,556099109,42036000.0,2260000,1.3750421154896684,2017-05-10,2017-03-31,0000950123-17-004280
N/A,Myovant Sciences Ltd.,G637AM102,38775000.0,3302835,1.2683713490368227,2017-05-10,2017-03-31,0000950123-17-004280
ALDR1EUR,Alder Biopharmaceuticals Inc.,014339105,35051000.0,1685150,1.1465553618333895,2017-05-10,2017-03-31,0000950123-17-004280
ITCIEUR,Intra-Cellular Therapies Inc.,46116X101,31281000.0,1925000,1.0232346658728784,2017-05-10,2017-03-31,0000950123-17-004280
ICPTUSD,Intercept Pharmaceuticals Inc.,45845P108,28922000.0,255719,0.9460692754827335,2017-05-10,2017-03-31,0000950123-17-004280
FPRX,Five Prime Therapeutics Inc.,33830X104,26299000.0,727500,0.8602681652693592,2017-05-10,2017-03-31,0000950123-17-004280
N/A,"AveXis, Inc.",05366U100,25303000.0,332800,0.8276879495726299,2017-05-10,2017-03-31,0000950123-17-004280
PRTA,Prothena Corp. PLC,G72800108,19527000.0,350000,0.6387488673795497,2017-05-10,2017-03-31,0000950123-17-004280
N/A,Novavax Inc.,670002104,10662000.0,8330000,0.34876532104269775,2017-05-10,2017-03-31,0000950123-17-004280
PBYI,Puma Biotechnology Inc.,74587V107,9137000.0,245616,0.2988809546395732,2017-05-10,2017-03-31,0000950123-17-004280
N/A,Cidara Therapeutics Inc.,171757107,8142000.0,1043824,0.26633345000278047,2017-05-10,2017-03-31,0000950123-17-004280
PTCT,PTC Therapeutics Inc.,69366J200,6720000.0,682912,0.2198183227731128,2017-05-10,2017-03-31,0000950123-17-004280
ACHNEUR,Achillion Pharmaceuticals Inc.,00448Q201,5386000.0,1279340,0.17618176881785502,2017-05-10,2017-03-31,0000950123-17-004280
